INNAMORATI, CHIARA
 Distribuzione geografica
Continente #
NA - Nord America 98
AS - Asia 65
EU - Europa 55
SA - Sud America 8
AF - Africa 1
OC - Oceania 1
Totale 228
Nazione #
US - Stati Uniti d'America 94
IT - Italia 29
SG - Singapore 26
VN - Vietnam 14
CN - Cina 11
RU - Federazione Russa 9
BR - Brasile 7
BD - Bangladesh 6
CA - Canada 4
CH - Svizzera 4
JP - Giappone 4
NL - Olanda 3
DE - Germania 2
FR - Francia 2
HK - Hong Kong 2
AL - Albania 1
AU - Australia 1
ES - Italia 1
FI - Finlandia 1
GB - Regno Unito 1
NO - Norvegia 1
PS - Palestinian Territory 1
SC - Seychelles 1
SK - Slovacchia (Repubblica Slovacca) 1
TR - Turchia 1
VE - Venezuela 1
Totale 228
Città #
San Jose 19
Rome 18
Singapore 17
Council Bluffs 14
Ashburn 9
Colorado Springs 5
Ho Chi Minh City 5
Hanoi 4
Los Angeles 4
Milan 4
Tokyo 4
Zurich 4
Montreal 3
New York 3
Orem 3
Santa Clara 3
Almere Stad 2
Beijing 2
Belo Horizonte 2
Denver 2
Hong Kong 2
Miramar 2
Paris 2
Atlanta 1
Bratislava 1
Buffalo 1
Cabo Frio 1
Chicago 1
Clermont 1
Concord 1
Da Nang 1
Dallas 1
Forney 1
Frankfurt am Main 1
Gjirokastër 1
Hangzhou 1
Helsinki 1
Houston 1
Huntsville 1
Irvine 1
Istanbul 1
London 1
Madrid 1
Manassas 1
Manaus 1
Miami 1
Milwaukee 1
Munich 1
Nha Trang 1
Ocala 1
Padua 1
Picayune 1
Portland 1
Redondo Beach 1
Ribeirão Preto 1
Santa Maria 1
Skedsmokorset 1
Sydney 1
São Paulo 1
The Dalles 1
Thái Bình 1
Toronto 1
Yaritagua 1
Totale 173
Nome #
Fluorescent Labeling Can Significantly Perturb Measured Binding Affinity and Selectivity of Peptide-Protein Interactions 90
Decoding C-SH2 Domain/Peptide Interactions in SH2 Domain-Containing Tyrosine Phosphatase 2: A Molecular Framework for Rational Inhibitor Design 47
Peptide inhibitors of proteinprotein interactions targeted to SRC homology 2 domains: a combined computational and spectroscopic design approach 34
Effects of peptide labeling on fluorescence binding assays to Src homology 2 domains: the case of protein-protein interactions inhibitors of the oncogenic phosphatase SHP2 34
A systematic framework for peptide-based inhibition of SHP2 protein-protein interactions 18
Decoupling SHP2 allosteric activation from binding to its phosphorylated partners 13
Exploring Protein Conformational Transitions in the Second Timescale through Multiscale Molecular Dynamics: The Case of SHP2 Activation 10
Inhibition of Protein-protein Interactions Involving Shp2: An Innovative Strategy Against Rtk-driven Cancers 8
Optimization of Peptide-based Inhibitors of Shp2 Oncogenic Protein: Towards Effective Drugs Against Rare Developmental Disorders and Juvenile Haematological Malignancies 7
Totale 261
Categoria #
all - tutte 870
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 870


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2024/202529 0 0 0 0 0 9 9 1 5 3 1 1
2025/2026213 4 3 5 8 6 3 40 28 22 27 17 50
2026/202719 19 0 0 0 0 0 0 0 0 0 0 0
Totale 261